Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors

INTRODUCTION: Inflammatory arthritis (IA) conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, are characterised by inflammatory infiltration of the joints. Biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic disease-modifying ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Malm, Esben, Nielsen, Sabrina Mai, Berg, Johannes, Ioannidis, John P. A., Furst, Daniel, Smolen, Josef S., Taylor, Peter C., Kristensen, Lars Erik, Tarp, Simon, Ellingsen, Torkell, Christensen, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422485/
https://www.ncbi.nlm.nih.gov/pubmed/34489286
http://dx.doi.org/10.1136/bmjopen-2021-049850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422485/
https://www.ncbi.nlm.nih.gov/pubmed/34489286
http://dx.doi.org/10.1136/bmjopen-2021-049850

Ejemplares similares